Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome

Lupus

Volumn 20, Issue 13, 2011, Pages 1356-1364

  Lozovoy, M A B ^a   Simao A N C ^b   Hohmann, M S N ^b   Simao T N C ^c   Barbosa, D S ^b   Morimoto, H K ^b   Reiche, E M V ^b   Cecchini, R ^b   Dichi, I ^b  

^a North University of Paraná UNOPAR   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

^c UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

Author keywords

inflammatory biomarkers; metabolic syndrome; oxidative stress; systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED OXIDATION PROTEIN PRODUCT; ANTIMALARIAL AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; LIPID HYDROPEROXIDE; PREDNISONE; SIMVASTATIN; URIC ACID;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM; SLE DISEASE ACTIVITY INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; RISK FACTORS; URIC ACID;

EID: 81555203187     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311411348     Document Type: Article

References (35)

1. Uramoto KM, Michet CJ, Thumboo J, Sunku J, óFallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 ; 42: 46-50 (Pubitemid 29042569)
2. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus. 2000 ; 9: 170-175 (Pubitemid 30199258)
3. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 338-346 (Pubitemid 29072852)
4. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes. 1988 ; 37: 1595-1607 (Pubitemid 19004941)
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national Health and Nutrition Examination Survey. JAMA. 2002 ; 287: 356-359 (Pubitemid 34251969)
6. Parker B, Bruce IN. The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin N Am. 2010 ; 36: 81-97
7. Vilar MJ, Azevedo GD, Gadelha RG, et al. Prevalence of metabolic syndrome and its components in Brazilian women with systemic lupus erythematosus: implications for cardiovascular risk. Ann Rheum Dis. 2006 ; 65 (Suppl 2). 362-362
8. Telles RW, Lanna CCD, Ferreira GA, Ribeiro AL. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics. Lupus. 2010 ; 19: 803-809
9. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 ; 102: 42-47 (Pubitemid 30430551)
10. Karp I, Abrahamowicz M, Fortin PR, et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?. Arthritis Rheum. 2008 ; 59: 169-175 (Pubitemid 351272950)
11. Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C. Cardiovascular risk in systemic lupus erythematosus - evidence of increased oxidative stress and dyslipidemia. Rheumatology. 2003 ; 42: 758-762 (Pubitemid 37220907)
12. Simão ANC, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and γ-glutamyltransferase on total antioxidant capacity an oxidative stress in patients with metabolic syndrome. Nutrition. 2008 ; 24: 675-681
13. Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity. 2010 ; 43: 56-63
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
16. Jacobs DR Jr. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
17. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 ; 45: 142-161 (Pubitemid 40066429)
18. Haffner SM, Miettinen H, Stern MP. The homeostasis model inthe San Antonio Heart Study. Diabetes Care. 1997 ; 20: 1087-1092 (Pubitemid 27274268)
19. Flecha BG, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Rad Biol Med. 1991 ; 10: 93-100 (Pubitemid 121003216)
20. Witko-Sarsat V, Friedlander M, Khoa TN, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998 ; 161: 2524-2532 (Pubitemid 28397070)
21. Sábio JM, Vargas-Hitos JA, Navarrete N, Hidalgo-Tenorio C, Jimenes-Alonso J. Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2010 ; 28: 483-489
22. El-Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in woman with systemic lupus erythematosus. J Rheumatol. 2006 ; 33: 50-56 (Pubitemid 43054279)
23. Chung CP, Avalos I, Oeser A, et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis. 2007 ; 66: 208-214 (Pubitemid 46226056)
24. Bellomio V, Spindler A, Lucero E, et al. Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus. 2009 ; 18: 1019-1025
25. Negrón AM, Molina MJ, Mayor AM, Rodriguez VE, Vilá LM. Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus. 2008 ; 17: 358-354
26. Borba EF, Carvalho JF, Bonfá E. Mechanism of dyslipoproteinemias in systemic lupus erythematosus. Clin Develop Immunol. 2006 ; 13: 203-208 (Pubitemid 44950038)
27. Svenungsson E, Gunnarsson I, Guo-Zhong F, et al. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythemathosus. Arthritis Rheum. 2003 ; 48: 2533-2540 (Pubitemid 37129431)
28. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord. 2000 ; 24: 23-27
29. Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, et al. Metabolic Syndrome in systemic lupus erythemathosus from Southern Spain. Lupus. 2008 ; 17: 849-859
30. Santos AC, Lopes C, Guimarães JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes. 2005 ; 29: 1452-1456 (Pubitemid 41622224)
31. Onat A, Uzunlar B, Hergenc G, et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci. 2005 ; 108: 129-135 (Pubitemid 40175406)
32. Wärnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR. AVENA Study Group, 2006. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006 ; 84: 505-512 (Pubitemid 44713399)
33. Van Oostrom AJ, Alipour A, Plokker TW, Sniderman AD, Cabezas MC. The metabolic syndrome in relation to complement component C3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis. 2006 ; 190: 167-173 (Pubitemid 44908311)
34. Turgay M, Durak I, Erten S, et al. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactivesystemic lupus erythematosus. Int J Rheum Dis. 2007 ; 10: 101-106 (Pubitemid 46831234)
35. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006 ; 290: 625-631